PTCT
PTC THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$65.37
−3.87%Forward multiples
Based on analyst estimates
- P/E forward
- 52.85x
- P/E 2026E
- 52.03x
- P/E 2027E
- 24.35x
- P/E 2028E
- 13.46x
- P/S forward
- 4.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -32.99x
- Price / sales
- 5.41x
- Price / cash flow
- -178.86x
Enterprise value
- Enterprise value
- $3.9B
- EV / sales
- 3.89x
- EV / EBITDA
- 22.61x
- EV / EBIT
- 33.75x
- Market cap
- $5.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026